M&T Bank
VIVO

M&T Bank’s Meridian Bioscience Inc VIVO Stock Holding History

M&T Bank’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11,917
Closed -$211K – 2276
2014
Q3 		$211K Buy
+11,917
New +$234K ﹤0.01% 1847

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

M&T Bank's VIVO Position: Q4 2014 in Review

M&T Bank sold out of Meridian Bioscience Inc (VIVO) in Q4 2014, closing a stake of 11,917 shares — an estimated $211K sold.

M&T Bank first reported a position in VIVO in Q3 2014 and held it in 1 quarter. The position peaked at $211K in Q3 2014. 160 funds tracked by Wall St. Rank hold VIVO as of Q4 2014.

  • M&T Bank reported no remaining Meridian Bioscience Inc position as of Q4 2014 after selling out during the quarter.
  • M&T Bank sold 11,917 Meridian Bioscience Inc shares in Q4 2014, an estimated $211K.
  • M&T Bank first reported a position in Meridian Bioscience Inc in Q3 2014 and held it in 1 quarter.
  • M&T Bank's Meridian Bioscience Inc position peaked at $211K in Q3 2014.
  • 160 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2014.

Based on M&T Bank's 13F filing for Q4 2014, filed 12 Feb 2015.